Series A - New Haven Pharmaceuticals - Oct 29, 2012 Funding Round Profile - Cointime

Bitcoin $94,057.63 -4.13%
Ethereum $3,444.66 +2.35%
BNB $637.57 -3.75%
Optimism $2.35 +7.22%
Arbitrum $0.93 +8.76%
Solana $236.36 -6.80%
Polygon $0.56 -3.30%
Cosmos $7.98 -8.94%
Avalanche $41.81 -0.38%

Bitcoin $94,057.63 -4.13%
Ethereum $3,444.66 +2.35%
BNB $637.57 -3.75%
Optimism $2.35 +7.22%
Arbitrum $0.93 +8.76%
Solana $236.36 -6.80%
Polygon $0.56 -3.30%
Cosmos $7.98 -8.94%
Avalanche $41.81 -0.38%

New Haven Pharmaceuticals

company

Funding Round

Series A

Money Raised

$ 6.49M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail